Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 3 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar d0319a (< 20) Submitted: 9/22/2009 8:26:41 AM : Outperform Start Price: $4.13 PTIE Score: -32.14

pipeline and cash

Report this Post Reply

Featured Broker Partners


Advertisement